Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of treating cancer by conjunctive therapy with N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent

US Patent 5646124 · Granted Jul 8, 1997

Assignee

Inventors

View full patent text on Google Patents →